What is Cerezyme (Genzyme)?
Cerezyme is an enzyme replacement therapy developed by Genzyme (now part of Sanofi). It’s used for treating certain lysosomal storage disorders, most commonly Gaucher disease (type 1, and in some cases pediatric or other specified patient groups depending on local prescribing guidance) [1].
Is Cerezyme the same thing as “Genzyme”?
No. “Genzyme” is the company name. “Cerezyme” is the brand name of a medicine. The company originally developed Cerezyme as an enzyme replacement product for Gaucher disease [1].
What’s the “genzyme” connection on prescriptions and labels?
You may see both names because:
- The medicine brand is “Cerezyme.”
- The manufacturer/brand owner historically is listed as Genzyme (with later corporate ownership changes reflected on labels and regulatory filings) [1].
Does Cerezyme still get produced and sold?
Cerezyme is an established prescription product tied to Genzyme/Sanofi corporate lineage, and it remains referenced in medical and regulatory documentation for Gaucher disease [1].
How does Cerezyme relate to other Gaucher enzyme therapies?
Cerezyme is one enzyme replacement option. Patients and clinicians typically compare enzyme replacement products and consider switching based on availability, dosing schedules, treatment goals, prior response, and country-specific approvals [1].
Common patient question: what is it used for?
Cerezyme is used to treat Gaucher disease by replacing a missing or deficient enzyme needed for breakdown of glycolipids in lysosomes. The exact indication (type of Gaucher disease, age group, and regimen) depends on the regulatory approval in the patient’s country [1].
---
Sources
[1] https://www.sanofi.com/en/our-therapies